Abstract: SA-PO300
Hypertension Associated with Herbal Supplements: “Diosmin Complex,” “Raphacholin C,” and “Herbatka Fix Na Cholesterol”: A Case Report
Session Information
- Trainee Case Reports - VI
October 27, 2018 | Location: Exhibit Hall, San Diego Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Trainee Case Reports
- 103 AKI: Mechanisms
Authors
- Bhullar, Jaibir, Avalon University School of Medicine, Youngstown , Ohio, United States
- Saini, Ravleen Kaur, Avalon University School of Medicine, Youngstown , Ohio, United States
- Jadidi, Shaheen, Midwestern University, Downers Grove, Illinois, United States
- Rauf, Rayaan A., Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States
- Udani, Suneel M., Nephrology Associates of Northern Illinois and Indiana, Oakbrook, Illinois, United States
Introduction
We report a case of hypertension associated with the ingestion of several Herbal Supplements (Diosmin Complex, Raphacholin C, and Herbatka Fix Na Cholestrol).
Case Description
A 60-year-old female patient, who had been ingesting these supplements sporadically for years, had increased her intake to twice a day for a month. Over the course of that month the patient developed palpitations, weight gain, trace edema, and mild jugular venous distention. Laboratory findings were notable for hypokalemia, hypocalcemia and hypomagnesemia with normal renal function. Urine chemistries confirmed mineralocorticoid excess with the presence of renal potassium wasting. The nutritional substance was subsequently ceased and supportive treatment was begun with low-dose carvedilol 6.25mg BID, and oral and IV potassium supplement. Further investigation was done of the renin aldosterone axis which confirmed the absence of primary hyperaldosteronism or high plasma renin activity. The patient’s condition improved rapidly with supportive treatment and ceasing of the supplements.
Discussion
Current information regarding the adverse effects of these herbal supplements is very scarce, therefore potential damage should be kept in mind before ingesting these nutritional supplements or anything similar. This report serves as an important reminder to the public, as well as healthcare providers, of the potential of hypertensive urgency related to such nutritional supplements.